drugset / Trial / NCT01009567
Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to investigate the efficacy and safety of cabergoline in prevention of ovarian hyperstimulation syndrome versus albumin in ART program.
Timeline
- Start
- 2009-06
- Primary completion
- 2013-06
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albumin | Protein / enzyme biologic | 20 g | Intravenous |
| Subject | Cabergoline | Small molecule | 0.5 mg | Oral |